Review of Radiation Therapy for Palmar and Plantar Fibromatosis (Dupuytren and Ledderhose Disease)

  • M. Heinrich SeegenschmiedtEmail author
  • Karin Piefel
  • Thomas Schneider


Palmar fibromatosis and plantar fibromatosis, called Dupuytren disease and Ledderhose disease (DD, LD), respectively, are chronic inflammatory and hyperproliferative connective tissue disorders which involve the palmar fascia of the hand and the plantar fascia of the foot, where they produce nodules, cords, and contractures; in addition, the overlaying subcutaneous fat and skin layers can be affected. These digitopalmar and digitoplantar alterations are part of a deforming and progressive, irreversible condition and part of a systemic connective tissue disorder (Enzinger and Weiss 1995), which is characterized by typical biochemical changes and additional fibrous deposits located at the dorsal PIP joint (forming knuckle pads), on the ear helix, the hand wrist, the elbow, and the penis forming a penile angulation (Peyronie disease). Although the tissue changes appear to have some pathohistological similarities, many studies and research efforts to identify a single cause of this generalized disorder have failed so far (Tomasek et al. 1999; Rudolph and Vande Berg 1991). Although numerous hypotheses exist about the disease onset and progression, the specific role of mesenchymal stem cells, fibroblasts, and myofibroblasts and the correlation with the clinical development of DD and LD are still not conclusively answered (Rödel and Seegenschmiedt 2016).


Radiotherapy Postoperative radiotherapy Palmar fibromatosis Dupuytren disease Ledderhose disease Plantar fibromatosis Clinical trial 


Conflict of Interest Declaration

The authors have no conflict of interest to declare.


  1. Adamietz B, Keilholz L, Grünert J, Sauer R (2001) Radiotherapy of early stage Dupuytren disease. Long-term results after a median follow-up period of 10 years. Strahlenther Onkol 177(11):604–610PubMedCrossRefGoogle Scholar
  2. Betz N, Ott OJ, Adamietz B, Sauer R, Fietkau R, Keilholz L (2010) Radiotherapy in early-stage Dupuytren’s contracture. Long-term results after 13 years. Strahlenther Onkol 186(2):82–90PubMedCrossRefGoogle Scholar
  3. Crocker I (1999) Radiation therapy to prevent coronary artery restenosis. Sem Rad Oncol 9:134–143CrossRefGoogle Scholar
  4. de Bree E, Zoetmulder FA, Keus RB, Peterse HL, van Coevorden F (2004) Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg 187(1):33–38Google Scholar
  5. Donato RR, Morrison WA (1996) Dupuytren’s disease in the feet causing flexion contractures in the toes. J Hand Surg Br 21(3):364–366PubMedCrossRefGoogle Scholar
  6. Eng TY, Boersma MK, Fuller CD et al (2006) The role of radiation therapy in benign diseases. Hematol Oncol Clin North Am 20(2):523–557PubMedCrossRefGoogle Scholar
  7. Enzinger FM, Weiss SW (1995) Soft tissue tumors, 3rd edn. CRC Press, St. LouisGoogle Scholar
  8. Falter E, Herndl E, Mühlbauer W (1991) Dupuytren’s contracture. When operate? Conservative preliminary treatment. Fortschr Med 109(10):223–226PubMedGoogle Scholar
  9. Finney R (1955) Dupuytren’s contracture. Br J Radiol 28(335):610–614, PMID:13269766PubMedCrossRefGoogle Scholar
  10. Grenfell S, Borg M (2014) Radiotherapy in fascial fibromatosis: a case series, literature review and considerations for treatment of early-stage disease. J Med Imaging Radiat Oncol 58(5):641–647PubMedCrossRefGoogle Scholar
  11. Herbst M, Regler G (1985) Dupuytrensche Kontraktur. Radiotherapie der Frühstadien. Strahlentherapie 161:143–147. PMID: 3975949Google Scholar
  12. Hesselkamp J, Schulmeyer M, Wiskemann A (1981) Röntgentherapie der Dupuytren der Dupuytrenschen Kontraktur im Stadium I. Therapiewoche 31: 6337–6338Google Scholar
  13. Heyd R, Dorn AP, Herkströter M et al (2010) Radiation therapy for early stages of morbus ledderhose. Strahlenther Onkol 186(1):24–29PubMedCrossRefGoogle Scholar
  14. Jansen JT, Broerse JJ, Zoetelief J et al (2005) Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel. Radiother Oncol 76(3):270–277PubMedCrossRefGoogle Scholar
  15. Kal HB, Veen RE (2005) Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship. Strahlenther Onkol 181(11):717–723PubMedCrossRefGoogle Scholar
  16. Keilholz L, Seegenschmiedt MH, Sauer R (1996) Radiotherapy for prevention of disease progression in early-stage Dupuytren’s contracture: initial and long-term results. Int J Radiat Oncol Biol Phys 36(4):891–897PubMedCrossRefGoogle Scholar
  17. Keilholz L, Seegenschmiedt MH, Born AD, Sauer R (1997) Radiotherapy in the early stage of Dupuytren’s disease. The indications, technique and long-term results. Strahlenther Onkol 173(1):27–35PubMedCrossRefGoogle Scholar
  18. Ketchum LD, Donahue TK (2000) The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg 25:1157–1162CrossRefGoogle Scholar
  19. Köhler AH (1984) [Radiotherapy of Dupuytren’s contracture] German, Radiobiol Radiother (Berl) 25(6):851–853. PMID: 6528027Google Scholar
  20. Kutzner J, Schneider L, Seegenschmiedt MH (2003) Radiotherapy of keloids. Patterns of care study -- results. Strahlenther Onkol 179(1):54–58PubMedCrossRefGoogle Scholar
  21. Leer JW, van Houtte P, Seegenschmiedt H (2007) Radiotherapy of non-malignant disorders: where do we stand? Radiother Oncol 83(2):175–177PubMedCrossRefGoogle Scholar
  22. Loos B, Puschkin V, Horch RE (2007) 50 years experience with Dupuytren’s contracture in the Erlangen University Hospital--a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord 8:60PubMedPubMedCentralCrossRefGoogle Scholar
  23. Lukacs S, Braun-Falco O, Goldschmidt H (1978) Radiotherapy of benign dermatoses: indications, practice, and results. J Dermatol Surg Oncol 4(8):620–625. PMID: 151104Google Scholar
  24. Mafi R, Hindocha S, Khan W (2012) Recent Surgical and Medical Advances in the Treatment of Dupuytren’s Disease - A Systematic Review of the Literature. Open Orthop J 6:77–82CrossRefGoogle Scholar
  25. McFarlane RM, McGrouther DA, Flint MH (1990) Dupuytren’s disease. Biology and treatment, The hand and upper limb series 5. Churchill Livingstone, EdinburghGoogle Scholar
  26. Millesi H (1981) Dupuytren-Kontraktur. In: Nigst H, Buck-Gramcko D, Millesi H (eds) Handchirurgie, Band I. Thieme, Stuttgart/New York, pp 1500–1557Google Scholar
  27. Murrell GAC, Francis MJO (1994) Oxygen free radicals and Dupuytren’s disease. In: Berger A, Delbrück A, Brenner P, Hinzmann R (eds) Dupuytren’s disease. Springer, Berlin/Heidelberg, pp 227–234CrossRefGoogle Scholar
  28. Murrell GAC, Francis MJO, Bromley L (1990) Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 165:659–665CrossRefGoogle Scholar
  29. Rayan GM, Parizi M, Tomasek JJ (1996) Pharmacological regulation of Dupuytren’s fibroblast contraction in vitro. J Hand Surg Am 21:1065–1070PubMedCrossRefGoogle Scholar
  30. Rödel F, Seegenschmiedt MH (2016) Introduction to radiation biology when treating hyperproliferative benign diseases. In: Werker PMN, Dias J, Eaton C, Reichert B, Wach W (eds) Dupuytren Disease and Related Diseases – The Cutting Edge. Springer International Publishing Switzerland, Cham, pp 333–339Google Scholar
  31. Rodemann HP, Bamberg M (1995) Cellular basis of radiation induced fibrosis. Radiother Oncol 35:83–90PubMedCrossRefGoogle Scholar
  32. Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH (1991) Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 5(4):1135–1142, discuss 1142–3PubMedGoogle Scholar
  33. Rubin P, Soni A, Williams JP (1999) The molecular and cellular biologic basis for radiation treatment of benign proliferative diseases. Sem Rad Oncol 9:203–214CrossRefGoogle Scholar
  34. Rudolph R, Vande Berg J (1991) The Myofibroblast in Dupuytren’s contracture. Hand Clin 7(4):683–692PubMedGoogle Scholar
  35. Sammarco GJ (2001) Osteotomy of the foot and ankle. Foot Ankle Clin 6(3):xi–xiiiPubMedCrossRefGoogle Scholar
  36. Schuster J, Saraiya S, Tennyson N et al (2015) Patient-reported outcomes after electron radiation treatment for early-stage palmar and plantar fibromatosis. Pract Radiat Oncol 5(6):e651–e658PubMedCrossRefGoogle Scholar
  37. Seegenschmiedt MH, Attassi M (2003) Radiation therapy for Morbus Ledderhose -- indication and clinical results. Strahlenther Onkol 179(12):847–853, GermanPubMedCrossRefGoogle Scholar
  38. Seegenschmiedt MH, Micke O (2012) Radiotherapy of non-malignant diseases. Past, present and future. Strahlenther Onkol 188(Suppl 3):272–290PubMedCrossRefGoogle Scholar
  39. Seegenschmiedt MH, Olschewski T, Guntrum F (2001) Radiotherapy optimization in early-stage Dupuytren’s contracture: first results of a randomized clinical study. Int J Radiat Oncol Biol Phys 49(3):785–798PubMedCrossRefGoogle Scholar
  40. Seegenschmiedt MH, Micke O, Willich N (2004) Radiation therapy for nonmalignant diseases in Germany. Current concepts and future perspectives. Strahlenther Onkol 180(11):718–730PubMedCrossRefGoogle Scholar
  41. Seegenschmiedt MH, Keilholz L, Wielpütz M et al (2012a) Long-Term outcome of radiotherapy for early stage Dupuytren’s disease: a phase III clinical study. In: Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker P, Wach W (eds) Dupuytren’s disease and related hyperproliferative disorders – principles, research, and clinical perspectives. Springer Publishers, Heidelberg/New York, pp 349–371CrossRefGoogle Scholar
  42. Seegenschmiedt MH, Wielpütz M, Hanslian E, Fehlauer F (2012b) Long-Term outcome of radiotherapy for early stage Dupuytren’s disease: a phase III clinical study. In: Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker P, Wach W (eds) Dupuytren’s disease and related hyperproliferative disorders – principles, research, and clinical perspectives. Springer Publishers, Heidelberg/New York, pp 409–427CrossRefGoogle Scholar
  43. Seegenschmiedt MH, Micke O, Muecke R, German Cooperative Group on Radiotherapy for Non-malignant Diseases (GCG-BD) (2015) Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol 88(1051):20150080PubMedPubMedCentralCrossRefGoogle Scholar
  44. Smitt MC, Donaldson SS (1999) Radiation therapy for benign disease of the orbit. Sem Rad Oncol 9:179–189CrossRefGoogle Scholar
  45. Strickland JW, Idler RS, Creighton JC (1990) Dupuytren’s disease. Indiana Med 83(6):408–409PubMedGoogle Scholar
  46. Suit H, Spiro I (1999) Radiation treatment of benign mesenchymal disease. Sem Rad Oncol 9:171–178CrossRefGoogle Scholar
  47. Terek RM, Jiranek WA, Goldberg MJ et al (1995) The expression of platelet-derived growth-factor gene in Dupuytren contracture. J Bone Joint Surg 77A:1–9Google Scholar
  48. Tomasek J, Rayan GM (1995) Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren’s disease fibroblasts. J Hand Surg Am 20:450–455PubMedCrossRefGoogle Scholar
  49. Tomasek JJ, Schultz RJ, Haaksma CJ (1987) Extracellular matrix-cytoskeletal connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease. J Bone Joint Surg 68(A):1400–1407Google Scholar
  50. Tomasek JJ, Vaughan MB, Haaksma CJ (1999) Cellular structure and biology of Dupuytren’s disease. Hand Clin 15(1):21–33, 02PubMedGoogle Scholar
  51. Tripuraneni P, Giap H, Jani S (1999) Endovascular brachytherapy for peripheral vascular disease. Sem Rad Oncol 199(9):190–202CrossRefGoogle Scholar
  52. Trott KR, Kamprad F (2006) Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol 182(8):431–436PubMedCrossRefGoogle Scholar
  53. Tubiana R, Michon J, Thomine JM (1966) Evaluation chiffree des deformations dans la maladie de Dupuytren. In: Maladie du Dupuytren (monographies du G.E.M.). Expansion Scientifique Francaise, ParisGoogle Scholar
  54. van der Veer WM, Hamburg SM, de Gast A, Niessen FB (2008) Recurrence of plantar fibromatosis after plantar fasciectomy: single-center long-term results. Plast Reconstr Surg 122(2):486–491PubMedCrossRefGoogle Scholar
  55. Vogt HJ, Hochschau L (1980) [The treatment of Dupuytren’s contracture. A social medical problem] German, MMW Munch Med Wochenschr. 122(4):125–130. PMID: 6767935Google Scholar
  56. Warwick D (2015) “Dupuytren’s disease FESSH instructional course 2015”. C.G. Edizioni Medico Scientifiche, TorinoGoogle Scholar
  57. Wasserburger K (1956) [Therapy of Dupuytren’s contracture]. Strahlentherapie 100(4):546–560. German. PMID: 13360519Google Scholar
  58. Weinzierl G, Flügel M, Geldmacher J (1993) Lack of effectiveness of alternative non-surgical treatment procedures of Dupuytren contracture. Chirurg 64(6):492–494PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • M. Heinrich Seegenschmiedt
    • 1
    Email author
  • Karin Piefel
    • 1
  • Thomas Schneider
    • 1
  1. 1.Strahlenzentrum Hamburg/Cyberknife Center HamburgHamburgGermany

Personalised recommendations